RTW INVESTMENTS, LP - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$619,000
-61.3%
126,3650.0%0.01%
-62.5%
Q3 2021$1,599,000
-18.2%
126,3650.0%0.02%
-17.2%
Q2 2021$1,954,000
-60.4%
126,365
-15.8%
0.03%
-62.3%
Q1 2021$4,937,000150,0000.08%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$23,927,0008.46%
Nan Fung Group Holdings Ltd 1,166,952$14,762,0004.72%
Novo Holdings A/S 4,503,991$56,975,0002.95%
Vivo Capital, LLC 3,871,291$48,972,0002.20%
Sofinnova Investments, Inc. 2,754,437$34,844,0002.06%
Samsara BioCapital, LLC 737,459$9,329,0001.46%
Ally Bridge Group (NY) LLC 257,267$3,254,0000.96%
Board of Trustees of The Leland Stanford Junior University 719,546$9,102,0000.68%
Rock Springs Capital Management LP 1,649,248$20,863,0000.44%
RA Capital Management 2,378,325$30,086,0000.42%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders